by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Curia New York, Inc. Warning Letter Details

Warning Letter

Curia New York, Inc.

Curia New York, Inc., 223 South West Street Raleigh , NC 27603 United States, (b)(4)

Issue DateSeptember 18, 2026

FEI Number1310298

Violations3

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

Curia New York, Inc. FDA Warning Letter, September 18, 2026